Owlet (OWLT) Research Hub

Owlet (OWLT) trades on NYSE, US in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 4.03 USD (-1.71%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.52, market cap 0.10B. This hub links to the full technical, earnings and options research available for OWLT.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNYSE, US
Last close4.03 USD (-1.71%)
52-week range4.03 USD – 6.74 USD
Trend regimeRange
14-day RSI19.7 (Oversold)
Trailing P/E-1.52
Market cap0.10B
Dividend yield0.00%
Next earnings2026-08-06

Available research for OWLT

Earnings

OWLT earnings date and last-quarter result: next report 2026-08-06, last quarter beat, P/E -1.52. Updated 2026-07-23.

Options: Covered Call

Covered Call on OWLT: how it works, illustrative setup around the real 4.03 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on OWLT: how it works, illustrative setup around the real 4.03 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on OWLT: how it works, illustrative setup around the real 4.03 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

OWLT technical analysis: range, last 4.03 USD, RSI 19.7, 52w range 4.03 USD–6.74 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is OWLT in?

Owlet (OWLT) is classified under Healthcare (Medical - Devices), listed on NYSE, US.

Is OWLT in an uptrend or downtrend?

As of 2026-10-26, OWLT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is OWLT's trailing P/E ratio?

OWLT's trailing P/E is -1.52, with a market cap of 0.10B. See the earnings research page for full valuation detail.

When does OWLT next report earnings?

OWLT is next scheduled to report earnings on 2026-08-06.